Mind-Body Balance for Pediatric Migraine
Trial Summary
You can continue taking your current prescribed nutraceuticals and preventive anti-migraine medications during the study, as long as you are on a stable dose. However, you should not take non-specific acute medications like ibuprofen more than 3 times a week or migraine-specific medications like triptans more than 6 times a month.
Research shows that mind-body therapies, like relaxation training and biofeedback, can effectively reduce headache frequency in children. A study found that nurse-administered relaxation training significantly reduced headache activity in children with chronic tension-type headaches, suggesting similar approaches could help with pediatric migraines.
12345Research on similar treatments like relaxation training and biofeedback for children with headaches shows they are generally safe and can reduce headache symptoms. These methods have been used in various studies without reports of harmful effects, suggesting they are safe for children.
35678The Mind-Body Balance treatment for pediatric migraine is unique because it involves mind-body therapies like relaxation training, which are non-drug approaches that help manage pain and anxiety through techniques such as meditation and guided imagery. This treatment is delivered in short sessions and can be administered by nurses, making it accessible and practical for children, especially in settings like schools.
12346Eligibility Criteria
This trial is for English-speaking individuals with migraines, experiencing 4 to 28 headache days per month. They should have a mild to severe impact on daily life but not be extremely disabled. Participants must be on stable migraine medication if used and agree not to overuse certain painkillers.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive a mind body skill introduction session and engage in home practice for headache management, with some receiving follow-up phone calls
Follow-up
Participants are monitored for changes in headache days and adherence to intervention components
Participant Groups
20 minute session is already approved in United States for the following indications:
- Pediatric Migraine